2001 Cannabinoids History Treatment 
Puff Puff Post
SEPTEMBER 24, 2019
The History and Science of Cannabis. On July 30 th , 2001, the government brought this into a legislative act known as the Medical Marijuana Access and Resources (MMAR). The medical prescription, referred to as the medical document, outlines the dosage of treatment (i.e. Anandamide (N-arachidonoyl ethanolamide) (AEA) .
CannaMD
AUGUST 26, 2020
A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
MAY 19, 2021
However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. In 2018, Epidolex became the first plant-derived cannabinoid prescription medicine to receive FDA approval. But in modern times? Shutterstock).
Ellementa
JULY 1, 2018
Women are turning to cannabinoids to help manage everything from hormonal emotional shifts to mood disorders and chronic anxiety — and they’re finding it safer and more effective than the pharmaceuticals they used to take. Turns out there’s a kernel of truth at the heart of the cartoonish “mellow stoner” stereotype.
Cannabis Law Report
AUGUST 5, 2021
In 2001, after many years of experience, active activism and tips sharing through online forums, Subcool founded together with his wife MZJill, a team of medicinal growers, the TGA Genetics seedbank. This strain overstands for its lemon taste and its high content of THCV, a cannabinoid known for its many medicinal properties.
Cannabis Law Report
AUGUST 19, 2019
Cannabinoids are the chemical substances found in cannabis. Over 100 different cannabinoids have been linked to the cannabis plant. To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. What substances are at issue? What is the relevant legislation?
Cannabis Law Report
AUGUST 27, 2022
The petitioners claimed that the treatment of cannabis at par with other harmful and lethal chemicals was arbitrary, unscientific and unreasonable. Further, while enacting the NDPS Act, Parliament did not take into consideration the positive effects of cannabis on human health and the history of use of cannabis in India, the petition stated.
Expert insights. Personalized for you.
94 
Let's personalize your content